These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11378074)

  • 21. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
    Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
    Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CGP57698: a structurally simple, highly potent peptido-leukotriene (pLT) antagonist of the quinoline type.
    von Sprecher A; Gerspacher M; Beck A; Anderson GP; Niederhauser U; Subramanian N; Ball HA; Gentsch C; Vassout A; Felner A; Bittiger H; Hauser K; Giese K; Kraetz J; Bray MA
    Adv Exp Med Biol; 1997; 433():169-72. PubMed ID: 9561127
    [No Abstract]   [Full Text] [Related]  

  • 23. Interferon-gamma modulates cysteinyl leukotriene receptor-1 expression and function in human airway myocytes.
    Amrani Y; Moore PE; Hoffman R; Shore SA; Panettieri RA
    Am J Respir Crit Care Med; 2001 Dec; 164(11):2098-101. PubMed ID: 11739141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of leukotriene D4 attenuates the development of seizures in mice.
    Rehni AK; Singh TG
    Prostaglandins Leukot Essent Fatty Acids; 2011 Aug; 85(2):97-106. PubMed ID: 21641195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
    Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
    Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of agonist and antagonist of cysteinyl leukotriene receptors on differentiation of rat glioma C6 cells].
    Cai BL; Wang XX; Yu SY; Huang XQ; Zhang XY; Fang SH; Lu YB; Zhang WP; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 40(2):139-44. PubMed ID: 21488208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-inflammatory effect of montelukast, a cysteinyl leukotriene receptor-1 antagonist, against estradiol-induced nonbacterial inflammation in the rat prostate.
    Said MM; Bosland MC
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):197-205. PubMed ID: 27909742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
    Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of cysteinyl receptor agonist and antagonists on rat primary cortical neurons].
    Hu X; Ge QF; Zhang WP; Wei EQ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 36(2):117-22. PubMed ID: 17443896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
    Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes.
    Bäck M; Norel X; Walch L; Gascard J; de Montpreville V; Dahlén S; Brink C
    Eur J Pharmacol; 2000 Aug; 401(3):389-95. PubMed ID: 10936498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
    Ishimura M; Kataoka S; Suda M; Maeda T; Hiyama Y
    Allergol Int; 2006 Dec; 55(4):403-10. PubMed ID: 17130683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of asthma with antileukotrienes: first line or last resort therapy?
    Dahlén SE
    Eur J Pharmacol; 2006 Mar; 533(1-3):40-56. PubMed ID: 16510137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Leukotriene D4 activates BV2 microglia in vitro].
    Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility.
    Corriveau S; Rousseau É; Blouin S; Pasquier JC
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():77-83. PubMed ID: 24735655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchyma.
    Ravasi S; Capra V; Panigalli T; Rovati GE; Nicosia S
    Biochem Pharmacol; 2002 Apr; 63(8):1537-46. PubMed ID: 11996896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leukotriene modifiers].
    Minoguchi K; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1979-85. PubMed ID: 11676142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
    Sener G; Sehirli O; Toklu H; Ercan F; Alican I
    J Pharm Pharmacol; 2007 Jun; 59(6):837-42. PubMed ID: 17637175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.